Physician

Sam L. Penza, M.D.

According to 2025 Medicare claims, Sam Penza, M.D. (NPI: 1356359640) practices unknown physician specialty in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU INTERNAL MEDICINE, LLC (NPI: 1740231448; TIN: 311369596) and primary practice location at 43210-1240. Penza is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Penza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 82 traditional Medicare patients, billed 329 HCPCS/CPT codes, and received $27,417 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 179 prescription claims across 24 beneficiaries totaling $3,242,107 in drug costs, led by Rezurock (Belumosudil Mesylate). Open Payments data shows 13 records totaling $13,085. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $43,287 and ending at $27,417. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $72,058 to $3,242,107. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	91	560	$43,287
2016	109	604	$46,460
2017	83	378	$27,880
2018	130	694	$52,136
2019	84	368	$26,619
2020	79	342	$25,376
2021	82	366	$29,894
2022	53	147	$10,731
2023	93	366	$32,065
2024	82	329	$27,417

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	18	135	$72,058
2016	15	67	$6,333
2017	N/R	16	$994
2018	15	67	$217,035
2019	13	82	$315,001
2020	14	52	$355,014
2021	16	54	$408,591
2022	21	129	$1,017,698
2023	23	145	$2,190,107
2024	24	179	$3,242,107

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	16	16	$98
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	11	14	$93
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	40	190	$89
99239	Hospital discharge day management, more than 30 minutes	15	16	$81
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	43	88	$69

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rezurock	Belumosudil Mesylate	95	2,850	$2,178,591
Jakafi	Ruxolitinib Phosphate	71	2,130	$1,062,876

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$13,085	Incyte Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sam L. Penza, M.D.?

Tedicare shows public-source Medicare data for Sam L. Penza, M.D. (NPI 1356359640), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sam L. Penza, M.D. have ACO affiliation data?

Sam L. Penza, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Sam L. Penza, M.D.?

Sam L. Penza, M.D. is linked to OSU INTERNAL MEDICINE, LLC (billing NPI 1740231448) in the available physician profile data.

Does Sam L. Penza, M.D. have Open Payments data?

Sam L. Penza, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.